<?xml version="1.0" encoding="UTF-8" ?>

       <rss version="2.0">

       <channel>

          <title>NewsVoir</title>

          <link>http://newsvoir.com</link><item>		

		 <title><![CDATA[Sahajanand Medical Technologies Achieves ISO 50001 Certification, Among Early Adopters in India's Cardiovascular Device Manufacturing Sector]]></title>

		 <link>http://newsvoir.com/index.php?option=com_content&amp;view=release&amp;rid=35442</link>

		 <description><![CDATA[Sahajanand Medical Technologies (SMT) has successfully obtained the ISO 50001:2018 Energy Management System certification for its manufacturing facilities in Surat and Hyderabad. The certification recognizes SMT's approach to optimizing energy use, strengthening environmental stewardship, and embedd....]]></description>

		 <pubDate><![CDATA[Tue, 28 Apr 2026 11:01:07]]></pubDate>

		 </item><item>		

		 <title><![CDATA[SMT's CEO Bhargav Kotadia Appointed Co-Chair of FICCI Medical Devices Committee 2025-2026]]></title>

		 <link>http://newsvoir.com/index.php?option=com_content&amp;view=release&amp;rid=34195</link>

		 <description><![CDATA[
	Sahajanand Medical Technologies (SMT), one of India's leading cardiovascular medical devices companies, is pleased to announce the appointment of Mr. Bhargav Kotadia, CEO & Managing Director, as the Co-Chair of the FICCI Medical Devices Committee for 2025-2026. This marks the fourth consecutive y....]]></description>

		 <pubDate><![CDATA[Tue, 23 Dec 2025 07:28:43]]></pubDate>

		 </item><item>		

		 <title><![CDATA[SMT's Hydra TAVR Valve Demonstrates Sustained Safety, Durability, and Hemodynamic Performance at 5 Years]]></title>

		 <link>http://newsvoir.com/index.php?option=com_content&amp;view=release&amp;rid=33837</link>

		 <description><![CDATA[
	Sahajanand Medical Technologies' (SMT) TAVR product Hydra's 5-year follow-up results from the pivotal Hydra CE Study were presented by Dr. Vilhelmas Bajoras at PCR London Valves 2025. The long-term data reaffirm Hydra's durable valve performance, sustained hemodynamic improvement, and favourable ....]]></description>

		 <pubDate><![CDATA[Wed, 19 Nov 2025 05:29:26]]></pubDate>

		 </item><item>		

		 <title><![CDATA[SMT Celebrates 20 Years of the Cocoon Occluder Journey, Transforming Lives in Congenital and Structural Heart Defects]]></title>

		 <link>http://newsvoir.com/index.php?option=com_content&amp;view=release&amp;rid=33747</link>

		 <description><![CDATA[
	Congenital Heart Disease (CHD) is one of the most common birth defects, affecting approximately 1% of live births globally and accounting for more than 4.18 million cases in children under five1. Despite advances in medical care, CHD continues to be a leading cause of infant and child mortality, ....]]></description>

		 <pubDate><![CDATA[Tue, 11 Nov 2025 06:56:11]]></pubDate>

		 </item><item>		

		 <title><![CDATA[SMT's Supraflex Cruz Shows Consistent and Robust Clinical Outcomes Across Key Global Studies Presented at TCT 2025]]></title>

		 <link>http://newsvoir.com/index.php?option=com_content&amp;view=release&amp;rid=33615</link>

		 <description><![CDATA[
	Sahajanand Medical Technologies (SMT) announced significant new findings from four landmark clinical studies, namely TUXEDO II, Multivessel TALENT, Cruz Senior Study, and the SFlex Netherlands Registry, presented at the TCT 2025 conference. The collective data reinforces the proven safety, effica....]]></description>

		 <pubDate><![CDATA[Wed, 29 Oct 2025 06:38:28]]></pubDate>

		 </item><item>		

		 <title><![CDATA[Positive 3-Year Results from FIRE Trial Demonstrate Supraflex Cruz's Safety and Efficacy in Elderly Heart Attack Patients]]></title>

		 <link>http://newsvoir.com/index.php?option=com_content&amp;view=release&amp;rid=33152</link>

		 <description><![CDATA[
	Sahajanand Medical Technologies (SMT), a medical devices company with a portfolio of technologically advanced medical devices across vascular and structural heart intervention, announced positive 3-year results from the FIRE Trial, presented at ESC 2025, reaffirming the safety and efficacy of its....]]></description>

		 <pubDate><![CDATA[Mon, 15 Sep 2025 06:36:08]]></pubDate>

		 </item>

</channel>

</rss>